Antihyperlipidemics - Statins: Nursing pharmacology

1,393views

Antihyperlipidemics - Statins: Nursing pharmacology

2144 final exam

2144 final exam

Skin cancer - Basal cell carcinoma, squamous cell carcinoma, and melanoma: Nursing
Burn injury: Nursing
Cutaneous fungal infections: Nursing
Folliculitis, carbuncles, and furuncles: Nursing
Herpes zoster: Nursing
Rocky Mountain spotted fever (RMSF): Nursing
Herpes simplex virus (HSV): Nursing
Hypersensitivity reactions - Type I: Nursing
Hypersensitivity reactions - Type III: Nursing
Hypersensitivity reactions - Overview: Nursing pathophysiology
Hypersensitivity reactions - Type IV: Nursing
Hypersensitivity reactions - Type II: Nursing
Stroke: Nursing pathophysiology
Stroke: Nursing process (ADPIE)
Case study - Stroke: Nursing
Hemorrhagic stroke - Intracranial hemorrhage (ICH) and subarachnoid hemorrhage (SAH): Nursing
Dementia: Nursing
Case study - Dementia: Nursing
Alzheimer disease
Delirium: Nursing
Case study - Delirium: Nursing
Atopic dermatitis: Nursing process (ADPIE)
Case study - Wound infection: Nursing
Erysipelas and cellulitis: Nursing
Chronic kidney disease (CKD): Nursing
Nephrotic syndrome: Nursing
Glomerulonephritis: Nursing
Urinary tract infections (UTIs): Nursing process (ADPIE)
Pyelonephritis: Nursing
Acute kidney injury (AKI): Nursing process (ADPIE)
Dialysis care: Nursing
Kidney disease: Nursing pathophysiology
Hypertension: Nursing pathophysiology
Hypertension: Nursing process (ADPIE)
Coronary artery disease (CAD) and angina pectoris: Nursing process (ADPIE)
Case study - Acute coronary syndrome (ACS): Nursing
Aneurysms
Heart failure: Pathology review
Heart failure: Nursing pathophysiology
Left-sided heart failure: Nursing process (ADPIE)
Anticoagulants - Heparin: Nursing pharmacology
Anticoagulants - Direct thrombin and factor Xa inhibitors: Nursing pharmacology
Anticoagulants - Warfarin: Nursing pharmacology
Antihyperlipidemics - Statins: Nursing pharmacology
Peripheral arterial disease (PAD): Nursing process (ADPIE)
Critical care - Pacemakers: Nursing
Pneumonia
Asthma: Nursing process (ADPIE)
Emphysema
Bronchodilators: Nursing pharmacology
Chronic bronchitis
Hyperthyroidism: Nursing process (ADPIE)
Syndrome of inappropriate antidiuretic hormone (SIADH): Nursing process (ADPIE)
Cushing syndrome and Cushing disease: Nursing
Adrenal insufficiency (Addison disease): Nursing
Diabetes mellitus: Nursing pathophysiology
Inflammatory bowel disease - Crohn disease and ulcerative colitis: Nursing
Carpal tunnel syndrome: Nursing
Fractures: Nursing process (ADPIE)
Acute compartment syndrome: Nursing process (ADPIE)
Osteomyelitis: Nursing
Osteoporosis: Nursing
Back pain: Pathology review
Osteoarthritis: Nursing
Rheumatoid arthritis (RA): Nursing process (ADPIE)
Osteoarthritis and rheumatoid arthritis: Nursing pathophysiology
Seronegative and septic arthritis: Pathology review
Neutropenia: Nursing
Anemia - Iron-deficiency: Nursing
Anemia - Aplastic: Nursing
Anemia: Nursing pathophysiology
Anemia - Macrocytic: Nursing

Notes

ANTIHYPERLIPIDEMICS: STATINS
DRUG NAME
simvastatin (Zocor, FloLipid), rosuvastatin (Crestor), atorvastatin (Lipitor), lovastatin (Altoprev), pravastatin
CLASS
HMG-CoA reductase inhibitors (statins)
MECHANISM OF ACTION
Bind and inhibit HMG-CoA reductase → decrease cholesterol synthesis → decrease cholesterol and LDL levels
INDICATIONS
  • Hypercholesterolemia
  • Increased LDL levels
  • Coronary artery disease
ROUTE(S) OF ADMINISTRATION
  • PO
SIDE EFFECTS
  • Headache, dizziness, insomnia, fatigue
  • Blurred vision, cataracts
  • Abdominal cramps, diarrhea, constipation, flatulence, heartburn, nausea
  • Liver dysfunction
  • Pancreatitis
  • Myalgia, rhabdomyolysis
  • Skin rash
  • Rosuvastatin: renal failure, pancytopenia
CONTRAINDICATIONS AND CAUTIONS
  • Active liver disease
  • Pregnancy
  • Breastfeeding
  • Drug interactions:
    • Cyclosporine, niacin, gemfibrozil, amiodarona, macrolides, antifungals: ↑ risk of rhabdomyolysis
    • Digoxin or warfarin: ↑ levels and toxicity
    • Oral contraceptives: ↑ estrogen levels
    • Protease inhibitors, erythromycin, gemfibrozil, grapefruit: statin toxicity
NURSING CONSIDERATIONS for ANTIHYPERLIPIDEMICS: STATINS
ASSESSMENT AND MONITORING
Assessment
  • Vital signs, cardiovascular status
  • Laboratory test results: CK, hepatic function and lipid panel; with female clients, negative pregnancy test

Monitoring
  • Periodic hepatic function, CK, lipid profile tests
  • Side effects
  • Therapeutic response: decreased LDL and triglyceride levels; improved cardiovascular health
CLIENT EDUCATION
  • Purpose of medication: decrease their LDL and triglyceride levels, decrease risk of coronary artery disease
  • Bedtime administration preferred
  • Avoid grapefruit and grapefruit juice
  • Limit alcohol
  • Female clients of childbearing age: use reliable contraception during treatment; inform healthcare provider if they become pregnant
  • Side effects
    • Gastrointestinal discomfort: eat small, frequent meals
    • Constipation: increase fluid and fiber intake
    • Symptoms to report
      • Rhabdomyolysis: unexplained muscle pain, weakness; brown urine
      • Liver impairment: fatigue, anorexia, nausea, dark urine, or yellowing of eyes or skin
      • Pancreatitis: abdominal pain that occurs after eating, especially pain in the upper abdomen; may radiate to their back
  • Lifestyle modifications
    • Smoking cessation weight control, physical activity, diet high in complex carbohydrates and fiber and low in saturated fat and cholesterol
Author: Victoria S. Recalde, MD
Author: Mary Roberts, MSN, RN
Illustrator: Robyn Hughes, MScBMC

Transcript

Watch video only

Antihyperlipidemics are medications used to treat clients with increased blood levels of lipids, like cholesterol, by decreasing the levels of low- density lipoproteins or LDLs, which is sometimes referred to as “bad” cholesterol; and to an extent, antihyperlipidemics can also decrease blood triglycerides.

In addition, they’re indicated to treat clients with coronary artery disease and prevent myocardial infarction.

Antihyperlipidemics include different classes of medications, among which some of the most commonly used are HMG-CoA reductase inhibitors, also called statins.

Statins include simvastatin, rosuvastatin, atorvastatin, lovastatin, and pravastatin, which are administered orally.

Once absorbed into the bloodstream, statins travel to the liver, where they inhibit the enzyme HMG-CoA reductase. As a result, there’s a decrease in cholesterol synthesis. This also causes hepatic cells to increase the number of LDL receptors on their surface.

This facilitates the uptake of cholesterol-rich LDLs, and VLDLs to a smaller degree, which provides a moderate decrease in triglyceride level. So ultimately, statins help lower overall lipid levels.

Luckily, statins are very well tolerated. The most common side effects include gastrointestinal symptoms like abdominal cramps, diarrhea or constipation, flatulence, heartburn, and nausea.

Especially with rosuvastatin, clients can develop a skin rash, and may experience headache and dizziness. Other side effects include blurred vision, cataracts, fatigue, and insomnia.

Some of the more serious side effects of statins include myalgia, and rhabdomyolysis, or muscle breakdown.

Next, although rare, statins can cause hepatotoxicity, especially in clients who already have a hepatic disease. Finally, simvastatin and atorvastatin can cause pancreatitis, while rosuvastatin can cause renal failure, and pancytopenia.

As far as contraindications go, statins are teratogenic, so they should be avoided during pregnancy. These medications are also contraindicated during breastfeeding and in clients with active hepatic disease, and should be used with caution in clients with a history of previous hepatic disease.

Regarding interactions, statins are metabolized in the liver by the enzyme cytochrome p450, so clients should avoid taking medications that enhance or inhibit this enzyme’s activity.

Special caution should be taken when combining statins with cyclosporine, niacin, gemfibrozil, amiodarone, macrolides, and antifungal medications, since they can increase the risk of rhabdomyolysis.

In addition, statins can also increase levels of digoxin and warfarin, as well as estrogen when taken with oral contraceptives.

Finally, clients on statins must avoid taking protease inhibitors, erythromycin, or gemfibrozil, as well as consuming grapefruit, as their interaction can increase the levels of statin and result in toxicity.

Okay, if a client with familial hypercholesterolemia is prescribed atorvastatin, start by performing a baseline assessment, including vital signs and cardiovascular status, noting any signs of coronary artery disease, including chest pain or shortness of breath.

Next, review recent laboratory results, specifically CK, hepatic function, and a lipid profile, which includes total cholesterol, triglycerides, HDL, and LDL, levels.

Sources

  1. "Karch’s Focus on Nursing Pharmacology, 9th edition" LWW (2023)
  2. "Pharmacology: A Patient-Centered Nursing Process Approach, 9th edition" Elsevier Canada (2020)
  3. "Mosby’s 2023 Nursing Drug Reference, 36th edition" Mosby (2022)
  4. "Saunders Comprehensive Review for the NCLEX-RN, 9th Edition" Saunders (2022)
  5. "Treatment with Statins in Elderly Patients" Medicina (Kaunas) (2019)
  6. "Effects of statins on mitochondrial pathways" J Cachexia Sarcopenia Muscle (2021)